Predictors of late mortality in cutaneous malignant melanoma - A population-based study in Sweden

International Journal of Cancer

Volumn 67, Issue 1, 1996, Pages 38-44

  Thörn, Magnus ^a   Bergström, Reinhold ^a,b   Hedblad, Marianne ^c   Lagerlöf, Bengt ^c   Ringborg, Ulrik ^c   Adami, Hans Olov ^a,d  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL;

ADULT; AGED; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; SKIN NEOPLASMS;

EID: 0030057814     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960703)67:1<38::AID-IJC9>3.0.CO;2-0     Document Type: Article

References (35)

1. BALCHC.M., The role of elective lymph node dissection in melanoma: rationale, results and controversies. J. clin. Oncol., 6, 163-172 (1988).
2. BALCHC.M., SOONG, S.-J., SHAW, H.M., URIST, M.M. and MCCARTHY, W.H., An analysis of prognostic factors in 8500 patients with cutaneous melanoma. In: C.M. Balch, A.N. Houghton and G.W. Milton (eds.). Cutaneous melanoma, 2nd ed., pp. 165-187, Lippincott, Philadelphia (1992).
3. BARNHILLR.L., FANDREY, K., LEVY, M.A., MIHM, M.C., JR. and HYMAN, B., Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma. Lab. Invest., 67, 331-337 (1992).
4. BRESLOWA., Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann. Surg., 172, 902-908 (1970).
5. BRESLOWN.E. and DAYN.E., Statistical methods in cancer research: the analysis of case-control studies. Vol. 1. IARC Scientific Publications, Lyon 32, 1980.
6. Cancer Incidence in Sweden 1960-1986. National Board of Health and Welfare, Stockholm (1963-1989).
7. CLARK W.H., JR., ELDER, D.E., GUERRY, D., IV, BRAITMAN, L.E., TROCK, B.J., SCHULTZ, D, SYNNESTVEDT, M. and HALPERN, A.C., Model predicting survival in stage I melanoma based on tumor progression. J. nat. Cancer Inst., 81, 1893-1904 (1989).
8. CLARKW.H., JR., FROM, L., BERNARDINO, E.A. and MIHM, M.C., The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res., 29, 705-727 (1969).
9. ELDHJ., Excisional biopsy and delayed wide excision versus primary wide excision of malignant melanoma. Scand. J. Plast. Reconstr. Surg., 13, 341-345 (1979).
10. EPSTEINE., BRAGG, K. and LINDEN, G., Biopsy and prognosis of malignant melanoma. J. Amer. med. Assoc., 208, 1369-1371 (1969).
11. FIDLERI.J., The biology of melanoma metastasis. In: C.M. Balch, A.N. Houghton and G.W. Milton (eds.), Cutaneous melanoma, 2nd ed., pp. 112-129, Lippincott, Philadelphia (1992).
12. FOLKMANJ., Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature (Medicine), 1, 27-31 (1995).
13. GARTNERM.F.R.M., FEARNS, C., WILSON, E.L., CAMPBELL, J.A.H. and DOWDLE, E.B., Unusual growth characteristics of human melanoma xenografts in the nude mouse: a model for desmoplasia, dormancy and progression. Brit. J. Cancer, 65, 487-490 (1992).
14. GUTMANM., KLAUSNER, J.M., INBAR, M. and ROZIN, R.R., Late recurrence of stage I malignant melanoma. J. surg. Oncol., 42, 96-98 (1989).
15. IRONSIDEP., PITT, T.T.E. and RANK, B.K., Malignant melanoma: some aspects of pathology and prognosis. Austr. N. Zeal. J. Surg., 47, 70-75 (1977).
16. KARAKOUSISC.P., TEMPLE, D.F., MOORE, R. and AMBRUS, J.L., Prognostic parameters in recurrent malignant melanoma. Cancer, 52, 575-579 (1983).
17. LANDTHALERM., BRAUN-FALCO, O., LEITL, A., KONZ, B. and HÖLZEL, D., Excisional biopsy as the first therapeutic procedure versus primary wide excision of malignant melanoma. Cancer, 64, 1612-1616 (1989).
18. LEDERMANJ.S. and SOBERA.J., Does biopsy type influence survival in clinical stage I cutaneous melanoma? J. Amer. Acad. Dermatol., 13, 983-987 (1985).
19. LEVYE., SILVERMAN, M.K., VOSSAERT, K.A., KOPF, A.W., BART, R.S., GOLOMB, F.M. and LEVENSTEIN, M.J., Late recurrence of malignant melanoma: a report of five cases, a review of the literature and a study of associated factors. Melanoma Res., 1, 63-67 (1991).
20. MCEWANL., SMITH, J.G. and MATTHEWS, J.P., Late recurrence of localized cutaneous melanoma: its influence on follow-up policy. Plast. Reconstr. Surg., 86, 527-534 (1990).
21. RAMPENF.H.J., VAN HOUTEN, W.A. and HOP, W.C.J., Incisional procedures and prognosis in malignant melanoma. Clin. exp. Dermatol, 5, 313-320 (1980).
22. SCHMOECKELC. and BRAUN-FALCOO., Prognostic index in malignant melanoma. Arch. Dermatol., 114, 871-873 (1978).
23. SHAFIES.M. and GRANTHAMF.H., Role of hormones in the growth and regression of human breast cancer cells (MCF-7) transplanted into athymic nude mice. J. nat. Cancer Inst., 67, 51-56 (1981).
24. SHAWH.M., BEATTIE, C.W., MCCARTHY, W.H. and MILTON, G.W., Late relapse from cutaneous stage I malignant melanoma. Arch. Surg., 120, 1155-1159 (1985).
25. SIMF.H., TAYLOR, W.F., PRITCHARD, D.J. and SOULE, E.H., Lymph-adenectomy in the management of stage I malignant melanoma: a prospective randomized study. Mayo Clin. Proc., 61, 697-705 (1986).
26. TAHERYD.P. and MOYR.L., Lack of predictive factors in late recurrence of stage I melanoma. Int. J. Dermatol., 31, 629-631 (1992).
27. THORNM., ADAMI, H.-O., RINGBORG, U., BERGSTRÖM, R. and KRUSEMO, U.B., Long-term survival in malignant melanoma with special reference to age and sex as prognostic factors. J. nat. Cancer Inst., 79, 969-974 (1987).
28. THÖRNM., ADAMI, H.-O., RINGBORG, U., BERGSTRÖM, R. and KRUSEMO, U.B., The association between anatomic site and survival in malignant melanoma. An analysis of 12,353 cases from the Swedish Cancer Registry. Europ. J. Cancer clin. Oncol., 25, 483-491 (1989).
29. THÖRNM., PONTÉN, F., BERGSTRÖM, R., SPARÉN, P. and ADAMI, H.-O., Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden. J. nat. Cancer Inst., 86, 761-769 (1994).
30. 1 lymphoma. Cancer Res., 51 (Suppl.), 5045-5053 (1991).
31. VERONESIU., and 20 OTHERS, Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer, 49, 2420-2430 (1982).
32. VOLLMERR.T., Malignant melanoma. A multivariate analysis of prognostic factors. Pathol. Ann., 24, 383-407 (1989).
33. WlJSMANJ.H., CORNELISSE, C.J., KEIJZER, R., VAN DE VELDE, C.J.H. and VAN DIERENDONCK, J.H., A prolactin-dependent, metastasizing rat mammary carcinoma as a model for endocrine-related tumour dormancy. Brit. J. Cancer, 64, 463-468 (1991).
34. WORTHA.J., GALLAGHER, R.P., ELWOOD, J.M., YANG, P.C., LAMB, C., SPINELLI, J.J., WOOD, W.S., THRELFALL, W.J. and HILL, G.B., Pathologic prognostic factors for cutaneous malignant melanoma: the Western Canada Melanoma Study. Int. J. Cancer, 43, 370-375 (1989).
35. YARNOLDJ.R. and COCHRANEJ.P.S., Malignant melanoma: significance of the disease-free interval. Brit. J. Radiol., 53, 1068-1070 (1980).